New:  International Biotechnology VC Directory 2009:
Including Biotechnology and Medical Device VC Sources.

Produced by BioAblity and published by BioWorld Today, the International Biotechnology VC Directory 2009 provides the most accurate and current profiles available of VC firms in the North America, Europe and Asia Pacific regions that are investing in the biotech industry. At over 550 pages, you can identify and learn about the VCs you should contact for your funding search.

This directory provides an excellent resource for biotechnology firms at any funding-stage: Seed, Series A-B, Series C-D, Mezzanine, Bridge, and Buyout. More than 950 VC firms are profiled at 1,595 locations. Multiple contacts are included for most firms, 2,884 contacts in all, with direct contact details, many including e-mail addresses.

Also included is an index of biotechnology and medical device companies with their corresponding VC partners, allowing you to target VCs that are investing in similar companies.

With this directory, you will be able to:

Ideal for:

>>Biotechnology Companies and Medical Device Firms seeking funding

>>Venture Capital Groups looking for co-investors and consortium members

>>Others interested in the worldwide Venture Capital players.

This report can be purchased in print or PDF.  $599. 

To order: Contact BioAbility for more information.

You can also order the data contained in this report in electronic format (MS Access or Excel format) for $990.  Click here for details.  To order the North American, European and or Asian VC data as a database in MS Excel or Access format, click here.

Biodefense and Homeland Security Reports

Two 2006 reports analyzing the current markets and competition for vaccines, therapeutics, diagnostics, and also the funding opportunities available for biodefense and homeland security

BioAbility has been involved in data collection, analysis, and report writing related to biodefense since 2001.

Biodefense Market Report: Vaccines, Therapeutics and Diagnostics for Bioterror Agents 2006

          ·        250 pages - 15% larger than 2005 edition.

·        Expanded profiles of products for SARS

·        Current products in development for avian influenza

·        Added section on diagnostics products and technologies

·        Market size analysis for various diseases

·        Details and status on 158 bioterror vaccines and 155 therapeutics

For details on this report and ordering, click here. 

 ***************************************

BioDefense and Homeland Security:  Opportunities for Life Science Companies 2006: Biodefense and Homeland Security: Opportunities for Life Science Companies 2006 is a new resource guide for companies trying to succeed in the biodefense industry!

At 273 pages, this Guide is 25 percent larger than our previous edition. The Biodefense and Homeland Security guide steers you through the labyrinth of opportunities, programs and procedures in the emerging biodefense industry. With a strong focus on actual companies that have become successful in biodefense, this report has become a valuable resource to many companies pursuing opportunities in this market. 

For details on this report and ordering, click here.

To order or for more information regarding these publications, contact BioAbility at 919.544.5111 info@bioability.com.